In sports and nutrition products news, Broadleaf Capital Partners (Stock Symbol: BDLF) subsidiary, Pipeline Nutrition USA, will market sports and nutrition products formulated by Human Performance, Exercise Science and Sport Studies Lab Director.
Online PR News – 04-July-2012 – Las Vegas, Nevada – Broadleaf Capital Partners, Inc. (Stock symbol: BDLF) announces the formation of a new subsidiary named Pipeline Nutrition USA, Inc. The new subsidiary will market sports and nutrition products formulated by Dr. Shawn M. Arent PhD who is a Professor and Director of the Human Performance Lab at the Department of Exercise Science and Sport Studies at Rutgers University.
At the Broadleaf Capital Partners, Inc. Annual Shareholders Meeting, held on May 4, 2012 in Las Vegas, Nevada, a quorum of its shareholders elected Donna M. Steward, Charles Snipes, and Robert McCoy as Directors and approved John Scrudato CPA as independent auditor for fiscal year end December 31, 2012. Over 139,922,205 shareholder votes were tallied at the Meeting out of 174,097,874 issued as of the record date of March 30, 2012.
The newly elected Board of Directors approved the formation of the new Pipeline Nutrition USA, Inc. sports and nutrition products marketing subsidiary.
Sports and nutrition products to be marketed by Pipeline Nutrition USA, Inc. will feature compounds within formulations by Dr. Arent that have had double blind, placebo controlled studies conducted for their safety and efficacy.
The new Chief Executive Officer of Pipeline Nutrition USA, Inc., K.C. Quintana said:
"We are excited to work with a diverse and experienced group of professionals and we are very confident our synergies will work well to maintain our product leadership."
About Broadleaf Capital Partners, Inc.
Broadleaf Capital Partners, Inc. (the "Company") is a reporting company with the Securities and Exchange Commission. The Company is seeking to expand its business model which was formerly was based on investments in real estate.
Forward Looking Statements: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended, (the "Exchange Act"). These forward-looking statements are subject to risks and uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from the results, performance or achievements expressed or implied by the forward-looking statements. You should not unduly rely on these statements. Factors, risks, and uncertainties that could cause actual results to differ materially from those in the forward-looking statements include, among others, the market acceptance of the products offered and sold by Pipeline Nutrition USA, Inc., our ability to finance growth, competition and governmental regulation of the sports nutrition industry.